A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver Genes

A Prospective Observational Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Driver Genes

A single-center, non-interventional prospective observational study in the NSCLC patients with different driver genes

The trial was designed as a single-center non-interventional prospective observational study to explore clinical treatments of the NSCLC patients with different driver genes, the impact factors of patient survivals, and the relevance of gene types, clinical treatments, and distribution of gene types. The follow-up visits, interactions between the investigators and patients, patient questionnaires/quality of life, and other patient information will be uploaded via mobile APP, and webchat every three months.

Inclusion Criteria:

• The patients with lung cancer who were performed with next-generation sequencing (NGS) technology from 2015 to 2017;
• The patients who were at least 18 years;
• The pathologically diagnosed patients with non-small cell lung cancer (NSCLC)

Exclusion Criteria:

-None